Kristoffer Jarlov Jensen
Biographic Data
| ID | 9802027 |
|---|---|
| NAME | Kristoffer Jarlov Jensen |
| GIVEN NAMES | Kristoffer Jarlov |
| FAMILY NAME | Jensen |
| SIGNATURE | JENSEN K J |
| AFFILIATIONS | University of Southern Denmark |
| ORCID | 0000-0001-9687-5706 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2020 |
| H-INDEX | 0 |
Seasonal variation in the non-specific effects of BCG vaccination on neonatal mortality
The BCG vaccine protects non-specifically against other diseases than tuberculosis. Three randomised controlled trials of early BCG in Guinea-Bissau found a 38% reduction in all-cause neonatal mortality. Little is known about the underlying mechanisms. In Guinea-Bissau, prevalent infectious diseases display distinct seasonality. Revisiting the three trials (>6500 infants) comparing early BCG versus no early BCG in low weight infants on all-cause …
BCG skin reactions by 2 months of age are associated with better survival in infancy
INTRODUCTION: Receiving Bacille Calmette-Guérin (BCG)-Denmark vaccine at birth has been associated with ~40% reductions in all-cause neonatal mortality. We evaluated determinants of BCG skin reaction characteristics by age 2 months and tested the association with subsequent mortality. METHODS: Prospective observational study amalgamating five trials providing BCG-at-birth that were conducted between 2002 and 2018 in Guinea-Bissau. The reaction st…
No prominent works on this page.
Seasonal variation in the non-specific effects of BCG vaccination on neonatal mortality
The BCG vaccine protects non-specifically against other diseases than tuberculosis. Three randomised controlled trials of early BCG in Guinea-Bissau found a 38% reduction in all-cause neonatal mortality. Little is known about the underlying mechanisms. In Guinea-Bissau, prevalent infectious diseases display distinct seasonality. Revisiting the three trials (>6500 infants) comparing early BCG versus no early BCG in low weight infants on all-cause …
BCG skin reactions by 2 months of age are associated with better survival in infancy
INTRODUCTION: Receiving Bacille Calmette-Guérin (BCG)-Denmark vaccine at birth has been associated with ~40% reductions in all-cause neonatal mortality. We evaluated determinants of BCG skin reaction characteristics by age 2 months and tested the association with subsequent mortality. METHODS: Prospective observational study amalgamating five trials providing BCG-at-birth that were conducted between 2002 and 2018 in Guinea-Bissau. The reaction st…
Environmental health (2 works) · History (2 works) · Immune responses and vaccinations (2 works) · Medicine (2 works) · New guinea (2 works) · Pediatrics (2 works) · BCG vaccine (1 work) · Child Nutrition and Water Access (1 work) · Demography (1 work) · Immunodeficiency and Autoimmune Disorders (1 work)